AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 4.140
-0.050 (-1.19%)
Sep 25, 2025, 4:08 PM HKT
AIM Vaccine Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 1,263 | 1,285 | 1,187 | 1,264 | 1,570 | 1,638 | Upgrade | |
Revenue Growth (YoY) | 6.62% | 8.22% | -6.06% | -19.49% | -4.14% | 72.12% | Upgrade |
Cost of Revenue | 356.06 | 331.52 | 1,799 | 236.41 | 275.43 | 267.66 | Upgrade |
Gross Profit | 906.45 | 953.51 | -611.21 | 1,028 | 1,295 | 1,370 | Upgrade |
Selling, General & Admin | 827.3 | 825.4 | 748.29 | 943.92 | 1,628 | 731.95 | Upgrade |
Research & Development | 299.98 | 363.13 | 636.4 | 500.31 | 307.35 | 157.76 | Upgrade |
Other Operating Expenses | - | - | - | - | - | 16.23 | Upgrade |
Operating Expenses | 1,125 | 1,182 | 1,389 | 1,471 | 1,943 | 906.76 | Upgrade |
Operating Income | -218.35 | -228.76 | -2,000 | -443.79 | -648.73 | 463.56 | Upgrade |
Interest Expense | -59.26 | -60.8 | -43.83 | -25.69 | -10.7 | -15.74 | Upgrade |
Interest & Investment Income | 5.45 | 7.49 | 10.71 | 10.69 | 10.78 | 10.74 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0.66 | - | 2.03 | 6.12 | Upgrade |
Other Non Operating Income (Expenses) | 21.84 | 24.09 | 27.52 | 21.55 | 38.25 | 21.91 | Upgrade |
EBT Excluding Unusual Items | -250.32 | -257.97 | -2,005 | -437.24 | -608.38 | 486.58 | Upgrade |
Impairment of Goodwill | - | - | -211.44 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 3.07 | 1.67 | 1.31 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 6.92 | - | - | -2.01 | Upgrade |
Asset Writedown | -32.75 | -32.75 | -61.09 | - | - | - | Upgrade |
Pretax Income | -283.07 | -290.72 | -2,271 | -434.17 | -606.7 | 485.89 | Upgrade |
Income Tax Expense | -13.87 | -12.25 | -320.4 | -203.54 | 69.17 | 85.47 | Upgrade |
Earnings From Continuing Operations | -269.2 | -278.47 | -1,950 | -230.63 | -675.87 | 400.41 | Upgrade |
Minority Interest in Earnings | 0.1 | 1.24 | 649.24 | -88.97 | -16.9 | -21.13 | Upgrade |
Net Income | -269.1 | -277.23 | -1,301 | -319.6 | -692.77 | 379.29 | Upgrade |
Net Income to Common | -269.1 | -277.23 | -1,301 | -319.6 | -692.77 | 379.29 | Upgrade |
Net Income Growth | - | - | - | - | - | 223.06% | Upgrade |
Shares Outstanding (Basic) | 1,216 | 1,211 | 1,211 | 1,203 | 1,163 | 963 | Upgrade |
Shares Outstanding (Diluted) | 1,216 | 1,211 | 1,211 | 1,203 | 1,163 | 963 | Upgrade |
Shares Change (YoY) | 0.41% | - | 0.71% | 3.44% | 20.78% | 15.37% | Upgrade |
EPS (Basic) | -0.22 | -0.23 | -1.07 | -0.27 | -0.60 | 0.39 | Upgrade |
EPS (Diluted) | -0.23 | -0.23 | -1.07 | -0.27 | -0.60 | 0.39 | Upgrade |
EPS Growth | - | - | - | - | - | 178.57% | Upgrade |
Free Cash Flow | -24.39 | -22.56 | -324.42 | -889.33 | -1,032 | -416.35 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.27 | -0.74 | -0.89 | -0.43 | Upgrade |
Gross Margin | 71.80% | 74.20% | -51.47% | 81.30% | 82.46% | 83.66% | Upgrade |
Operating Margin | -17.29% | -17.80% | -168.43% | -35.11% | -41.32% | 28.30% | Upgrade |
Profit Margin | -21.31% | -21.57% | -109.56% | -25.28% | -44.12% | 23.16% | Upgrade |
Free Cash Flow Margin | -1.93% | -1.75% | -27.32% | -70.35% | -65.73% | -25.42% | Upgrade |
EBITDA | -97.18 | -97.67 | -1,859 | -307.38 | -529.57 | 569.96 | Upgrade |
EBITDA Margin | -7.70% | -7.60% | -156.53% | -24.32% | -33.73% | 34.80% | Upgrade |
D&A For EBITDA | 121.17 | 131.09 | 141.38 | 136.41 | 119.16 | 106.4 | Upgrade |
EBIT | -218.35 | -228.76 | -2,000 | -443.79 | -648.73 | 463.56 | Upgrade |
EBIT Margin | -17.29% | -17.80% | -168.43% | -35.11% | -41.32% | 28.30% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 17.59% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.